| Trial ID: | L0969 |
| Source ID: | NCT00892749
|
| Associated Drug: |
Asp1585
|
| Title: |
Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Renal Dialysis|Renal Insufficiency|Hyperphosphatemia
|
| Interventions: |
DRUG: ASP1585
|
| Outcome Measures: |
Primary: Changes in serum Phosphorus level, After 48 weeks | Secondary: Percent of the patients meeting the target range of serum Phosphorus levels, During the treatment|Changes in serum Calcium level, After 48 weeks|Changes in serum Ca x P, After 48 weeks|Changes in intact PTH level, After 48 weeks
|
| Sponsor/Collaborators: |
Sponsor: Astellas Pharma Inc
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
248
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-05
|
| Completion Date: |
2010-09
|
| Results First Posted: |
|
| Last Update Posted: |
2015-05-04
|
| Locations: |
Chubu, Japan|Chugoku, Japan|Kansai, Japan|Kantou, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT00892749
|
